DK227390A - Vaevsplasminogenaktivatorvarianter - Google Patents

Vaevsplasminogenaktivatorvarianter Download PDF

Info

Publication number
DK227390A
DK227390A DK227390A DK227390A DK227390A DK 227390 A DK227390 A DK 227390A DK 227390 A DK227390 A DK 227390A DK 227390 A DK227390 A DK 227390A DK 227390 A DK227390 A DK 227390A
Authority
DK
Denmark
Prior art keywords
variants
plasminogen activator
tissue plasminogen
disclosed
fibrin binding
Prior art date
Application number
DK227390A
Other languages
English (en)
Other versions
DK227390D0 (da
DK175776B1 (da
Inventor
Stephen P Anderson
Deborah L Higgins
Adair J Hotchkiss
Cara B Marks
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22620139&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK227390(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of DK227390A publication Critical patent/DK227390A/da
Publication of DK227390D0 publication Critical patent/DK227390D0/da
Application granted granted Critical
Publication of DK175776B1 publication Critical patent/DK175776B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Artificial Filaments (AREA)
  • Inorganic Fibers (AREA)
DK199002273A 1988-03-21 1990-09-20 Varianter af human vævsplasminogenaktivator og fremgangsmåde til fremstilling deraf DK175776B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US17051088 1988-03-21
US07/170,510 US5094953A (en) 1988-03-21 1988-03-21 Human tissue plasminogen activator variants
PCT/US1989/000896 WO1989009266A1 (en) 1988-03-21 1989-03-06 Novel human tissue plasminogen activator variants and processes
US8900896 1989-03-06

Publications (3)

Publication Number Publication Date
DK227390A true DK227390A (da) 1990-09-20
DK227390D0 DK227390D0 (da) 1990-09-20
DK175776B1 DK175776B1 (da) 2005-02-14

Family

ID=22620139

Family Applications (1)

Application Number Title Priority Date Filing Date
DK199002273A DK175776B1 (da) 1988-03-21 1990-09-20 Varianter af human vævsplasminogenaktivator og fremgangsmåde til fremstilling deraf

Country Status (13)

Country Link
US (4) US5094953A (da)
EP (1) EP0401303B2 (da)
JP (2) JP2605155B2 (da)
AT (1) ATE107960T1 (da)
AU (1) AU635892B2 (da)
CA (1) CA1341612C (da)
DE (1) DE68916532T3 (da)
DK (1) DK175776B1 (da)
ES (1) ES2018367A6 (da)
GR (1) GR1000387B (da)
IL (1) IL89500A (da)
NZ (1) NZ228401A (da)
WO (1) WO1989009266A1 (da)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU200615B (en) * 1982-05-05 1990-07-28 Genentech Inc Methods of preparing tissue plasiminogen activator derivative composition
FI831484A7 (fi) * 1982-05-05 1983-11-06 Genentech Inc Ihmiskudoksen plasminogeenien aktivaattori.
US5714372A (en) * 1985-04-22 1998-02-03 Genentech, Inc. Tissue plasminogen activator variants
KR970005046B1 (ko) * 1987-10-29 1997-04-11 야마노우찌 세이야꾸 가부시끼가이샤 개량형 조직 플라스미노겐 활성화 인자
DE3923339A1 (de) * 1989-05-31 1990-12-06 Boehringer Mannheim Gmbh Gewebs-plasminogen-aktivator-derivat
US5242688A (en) * 1990-12-24 1993-09-07 Eli Lilly And Company Method of treating thromboembolic disorders by administration of diglycosylated t-pa variants
US5595736A (en) * 1991-04-22 1997-01-21 Eli Lilly And Company Compounds and methods for treatment of thromboembolic disorders
US5468505A (en) * 1992-02-28 1995-11-21 Board Of Regents, The University Of Texas System Local delivery of fibrinolysis enhancing agents
US5811252A (en) * 1994-07-07 1998-09-22 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno Modified proenzymes as substrates for proteolytic enzymes
US6136548A (en) * 1994-11-22 2000-10-24 Rutgers, The State University Of New Jersey Methods for identifying useful T-PA mutant derivatives for treatment of vascular hemorrhaging
US6461640B1 (en) 1995-12-08 2002-10-08 Board Of Regents, The University Of Texas System Local delivery of fibrinolysis enhancing agents
US20030113271A1 (en) * 1997-01-29 2003-06-19 University Technology Corporation Formulations for pulmonary delivery
AU729489B2 (en) * 1997-07-23 2001-02-01 Roche Diagnostics Gmbh Production of human mutated proteins in human cells by means of homologous recombination
US6136536A (en) * 1997-10-29 2000-10-24 Genetics Institute, Inc. Rapid generation of stable mammalian cell lines producing high levels of recombinant proteins
US6283300B1 (en) 1998-08-21 2001-09-04 Joseph B. Bielagus Feed distribution for low velocity air density separation
US6242473B1 (en) 1999-01-08 2001-06-05 Maxim Pharmaceuticals, Inc. Treatment and prevention of reactive oxygen metabolite-mediated cellular damage
JP3880036B2 (ja) * 2001-05-11 2007-02-14 全国酪農業協同組合連合会 タンパク質の濃縮方法
DE10153601A1 (de) * 2001-11-02 2003-05-22 Paion Gmbh DSPA zur Behandlung von Schlaganfall
EP1448127A1 (en) * 2001-11-06 2004-08-25 Maxim Pharmaceuticals, Inc. Compositions for the treatment of infectious diseases
US20080057050A1 (en) * 2003-05-02 2008-03-06 Paion Deutschland Gmbh Intravenous injection of plasminogen non-neurotoxic activators for treating cerebral stroke
DE10342518A1 (de) * 2003-09-12 2005-05-12 Paion Gmbh Plasminogen-Aktivatoren mit verringerter Lysin-Bindungskapazität
AR068914A1 (es) * 2007-10-18 2009-12-16 Paion Deutschland Gmbh Uso de un activador de plasminogeno para la preparacion de un medicamento para el tratamiento de apoplejia
WO2015023830A1 (en) 2013-08-14 2015-02-19 Stc.Unm Treatment and prevention of stroke and other neurological disorders

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR861037B (en) * 1985-04-22 1986-07-16 Genentech Inc Novel human tissue plasminogen activator mutants
ES2031826T3 (es) * 1985-12-23 1993-01-01 Chiron Corporation Procedimiento para producir nuevos peptidos activadores del plasminogeno.
WO1987004722A1 (en) * 1986-01-31 1987-08-13 Genetics Institute, Inc. Novel thrombolytic proteins
EP0234051B1 (en) * 1986-02-17 1991-12-11 Stichting Centraal Laboratorium van de Bloedtransfusiedienst van het Nederlandse Rode Kruis Tissue-type plasminogen activator mutants; recombinant genetic information coding therefor and process for preparing said mutants; their use and pharmaceutical compositions
PT84588B (en) * 1986-04-02 1989-05-09 Beecham Group Plc Process for preparing a fibrinolytic enzyme
SE8702562L (sv) * 1987-06-18 1988-12-19 Kabigen Ab Nya fibrinolytiska enzymer
US4935237A (en) * 1988-03-21 1990-06-19 Genentech, Inc. Processes for the preparation of t-PA mutants
IL87276A (en) * 1987-08-03 1995-07-31 Fujisawa Pharmaceutical Co Analog of tissue plasminogen activator comprising only the kringle 2 and protease domain dna encoding the same processes for the preparation thereof and pharmaceutical compositions containing the same
EP0386240B1 (en) * 1987-10-29 1995-07-19 Yamanouchi Pharmaceutical Co. Ltd. Novel polypeptide compounds
DE3937589C2 (de) * 1989-11-10 2001-12-13 Laing Oliver Zirkulationsgerät mit Widerstandsheizung

Also Published As

Publication number Publication date
NZ228401A (en) 1991-09-25
GR1000387B (el) 1992-06-30
AU635892B2 (en) 1993-04-08
US5770425A (en) 1998-06-23
AU3414889A (en) 1989-10-16
IL89500A0 (en) 1989-09-10
EP0401303B2 (en) 1999-11-03
DE68916532T3 (de) 2000-02-03
IL89500A (en) 1998-09-24
EP0401303A1 (en) 1990-12-12
JPH09168387A (ja) 1997-06-30
US5094953A (en) 1992-03-10
JPH03503363A (ja) 1991-08-01
DE68916532T2 (de) 1995-01-12
ES2018367A6 (es) 1991-04-01
DK227390D0 (da) 1990-09-20
DK175776B1 (da) 2005-02-14
JP2605155B2 (ja) 1997-04-30
DE68916532D1 (de) 1994-08-04
EP0401303B1 (en) 1994-06-29
WO1989009266A1 (en) 1989-10-05
US5366886A (en) 1994-11-22
CA1341612C (en) 2011-04-12
US5314818A (en) 1994-05-24
ATE107960T1 (de) 1994-07-15
GR890100164A (en) 1990-01-19

Similar Documents

Publication Publication Date Title
DK227390D0 (da) Vaevsplasminogenaktivatorvarianter
ATE279430T1 (de) Verfahren zur verbesserung der serum halbwertszeit von biologisch aktiven molekülen
DE69514342D1 (de) Modifizierte polypeptide mit erhoehter biologischer aktivitaet
FI943632A0 (fi) Kudosplasminogeeniaktivaattorin glykosylaatiomuunnelmat terapeuttisten ominaisuuksien parantamiseksi
IE831024L (en) Human tissue plasminogen activator
DK1149905T3 (da) Fremgangsmåder og præparat til polypeptidteknologi
DK135887A (da) Human-vaevstype-plasminogenaktivator-polypeptider og fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende disse
DK431988D0 (da) Protein og dna til kodning deraf
EP0355068A3 (en) Recombinant hybrid immunoglobulin molecules and their use
DE69120287D1 (en) Aminosulfonylharnstoff-acat-inhibitoren
DK0669394T3 (da) Bifunktionelle urokinasevarianter med forbedrede fibrinolytiske egenskaber og thrombinhæmmende virkninger
AU669149B2 (en) Expression signal-peptide-free staphylokinases
EP0339505A3 (en) Monoclonal antibodies to tissue plasminogen activator (t-pa) which prolong its functional half-life
DK167021C (da) Substituerede thiacykloalkene oe3,2-baapyridiner, fremgangsmaade til fremstilling deraf og praeparater indeholdende disse
PT86771A (pt) Process for preparing 4-substituted benzamide derivatives with anticonvulsant activity
FI102970B (fi) Menetelmä ihmisen kudostyyppisen plasminogeeniaktivaattorimuunnelman v almistamiseksi
DK0542869T3 (da) Vævsplasminogenaktivatorvarianter med nedsat udskillelse
Zolotaryeva Estimating the. role of plasmin catalytic chain regulatory site in fibrinogenolysis
NO902405D0 (no) Vevplasminogenaktivatorderivat, dna-sekvens og ekspresjonsplasmid, samt fremgangsmaate for fremstilling av plasmidet.
DK0563280T3 (da) Vævsplasminogenaktivator substitutionsvariant

Legal Events

Date Code Title Description
PUP Patent expired